Prevalence of Hepatitis B and C Virus Markers in Outpatients of Mongolian General Hospitals
In East Asian countries, the prevalence of viral hepatitis has been reported to be high, but precise data for each country remained to be investigated. Here we report the prevalence of viral markers of hepatitis B and hepatitis C in outpatient volunteers visiting two general hospitals in Ulaanbaatar...
Gespeichert in:
| Veröffentlicht in: | Kansenshogaku Zasshi 1998/01/20, Vol.72(1), pp.5-11 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 11 |
|---|---|
| container_issue | 1 |
| container_start_page | 5 |
| container_title | Kansenshogaku Zasshi |
| container_volume | 72 |
| creator | FUJIOKA, Shin-ichi SHIMOMURA, Hiroyuki ISHII, Yasushi KONDO, Jun-ichi FUJIO, Kozo IKEDA, Fusao MIYAKE, Masanobu KUSACHI, Shozo TSUJI, Takao |
| description | In East Asian countries, the prevalence of viral hepatitis has been reported to be high, but precise data for each country remained to be investigated. Here we report the prevalence of viral markers of hepatitis B and hepatitis C in outpatient volunteers visiting two general hospitals in Ulaanbaatar, Mongolia. One hundred fifty sera were tested for HBs antigen (HBsAg), anti-HBs, and anti-HCV by Counting Immunoassay. The backgrounds of groups of patients positive for HBsAg and negative for anti-HCV (group 1; n=18), negative for HBsAg and positive for anti-HCV (group 2: n=47), positive for both HBsAg and anti-HCV (group 3; n=25), and negative for both HBsAg and anti-HCV (group 4; n=60) were compared. The prevalence of HBsAg, anti-HBs, and anti-HCV in this study group was 28.7%, 39.3% and 48.0%, respectively. Sugjects of group 1 (mean±SD; 31.3±12.4 years old) were younger than those of group 4 (39.2±14.3; p |
| doi_str_mv | 10.11150/kansenshogakuzasshi1970.72.5 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79733076</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79733076</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3895-7b9f9fd1686a5befcaa39d65fdd3041c823157da885e5971ccb941b4e44427c13</originalsourceid><addsrcrecordid>eNp9kEFPGzEQha2qiEbAT6jkS3vb1F6v1-tDD20EpBIIkFqE1IM1651N3Gy8wbOLRH89oYlyo5d5h_e9N9Jj7JMUUymlFl9WEAkjLfsFrMa_QLQM0hoxNflUv2MTWVVFpkv78J5NhKpMpq2UH9gZUaiFELYQuc6P2bHVQhljJuz3bcIn6DB65H3L57iBIQyB-HcOseEzfh_SSPwa0goT8RD5zTi8MhgHek1c93HRdwEiv8SICTo-72kTBujolB21W8GzvZ6wXxfnP2fz7Orm8sfs21XmVWV1Zmrb2raRZVWCrrH1AMo2pW6bRolC-ipXUpsGqkqjtkZ6X9tC1gUWRZEbL9UJ-7zr3aT-cUQa3DqQx66DiP1IzlijlDDlFvy6A33qiRK2bpPCGtKzk8L929e9sa8zudPb_Mf9o7FeY3NI79fc-nc7_w8NsMCDD2kIvsP_lcvd0QfWLyE5jOoFqSmcpQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79733076</pqid></control><display><type>article</type><title>Prevalence of Hepatitis B and C Virus Markers in Outpatients of Mongolian General Hospitals</title><source>J-STAGE Free</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>FUJIOKA, Shin-ichi ; SHIMOMURA, Hiroyuki ; ISHII, Yasushi ; KONDO, Jun-ichi ; FUJIO, Kozo ; IKEDA, Fusao ; MIYAKE, Masanobu ; KUSACHI, Shozo ; TSUJI, Takao</creator><creatorcontrib>FUJIOKA, Shin-ichi ; SHIMOMURA, Hiroyuki ; ISHII, Yasushi ; KONDO, Jun-ichi ; FUJIO, Kozo ; IKEDA, Fusao ; MIYAKE, Masanobu ; KUSACHI, Shozo ; TSUJI, Takao</creatorcontrib><description><![CDATA[In East Asian countries, the prevalence of viral hepatitis has been reported to be high, but precise data for each country remained to be investigated. Here we report the prevalence of viral markers of hepatitis B and hepatitis C in outpatient volunteers visiting two general hospitals in Ulaanbaatar, Mongolia. One hundred fifty sera were tested for HBs antigen (HBsAg), anti-HBs, and anti-HCV by Counting Immunoassay. The backgrounds of groups of patients positive for HBsAg and negative for anti-HCV (group 1; n=18), negative for HBsAg and positive for anti-HCV (group 2: n=47), positive for both HBsAg and anti-HCV (group 3; n=25), and negative for both HBsAg and anti-HCV (group 4; n=60) were compared. The prevalence of HBsAg, anti-HBs, and anti-HCV in this study group was 28.7%, 39.3% and 48.0%, respectively. Sugjects of group 1 (mean±SD; 31.3±12.4 years old) were younger than those of group 4 (39.2±14.3; p <0.05), while patients of group 2 (48.7±15.5) were older than those of group 4 (p < 0.01). More group 2 subjects had histories of jaundice (23/47) than those of group 4 (15/60; p <0.05). Transaminase levels were higher in group 1 (median range) IU/ 1 of AST, ALT; 29 (13-95), 32 (9-144) and group 3 (25 (15-187), 22 (8-185)) than in group 4 (18 (9-13), 15 (6-133); p <0.05, p <0.005 vs. group 1, and p <0.005, p <0.001 vs. group 3, respec ively). In HBsAg-negative subjects, those with higher titers of anti-HCV (cut-off index > 15) were older, and had more histories of jaundice and higher levels of AST and ALT than anti-HCV negative subjects (50.3±14.8 vs. 39.1±14.3, p<0.01; 15/28 vs. 15/60, p<0.01; 22.5 (12-127) vs. 18 (9-93), p<0.05; 20.5 (7-362) vs. 15 (6-133), p <0.05; respectively). In conclusion, this preliminary surveillance for hepatitis B and C viral markers showed that both hepatitis viruses are prevalent and may cause liver diseases in Mongolia. A nation-wide survery for these viruses should be urged and preventive measures should be taken to suppress the spread and development of liver diseases in this country.]]></description><identifier>ISSN: 0387-5911</identifier><identifier>EISSN: 1884-569X</identifier><identifier>DOI: 10.11150/kansenshogakuzasshi1970.72.5</identifier><identifier>PMID: 9503777</identifier><language>eng</language><publisher>Japan: The Japanese Association for Infectious Diseases</publisher><subject>Adult ; Biomarkers - blood ; epidemiology ; Female ; hepatitic C virus ; Hepatitis B - epidemiology ; Hepatitis B Antibodies - blood ; Hepatitis B Surface Antigens - blood ; hepatitis B virus ; Hepatitis C - epidemiology ; Hepatitis C Antibodies - blood ; Hospitals, General ; Humans ; Male ; Middle Aged ; mongolia ; Mongolia - epidemiology ; Outpatients ; Prevalence</subject><ispartof>Kansenshogaku Zasshi, 1998/01/20, Vol.72(1), pp.5-11</ispartof><rights>The Japansese Association for Infectious Diseases</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3895-7b9f9fd1686a5befcaa39d65fdd3041c823157da885e5971ccb941b4e44427c13</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9503777$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FUJIOKA, Shin-ichi</creatorcontrib><creatorcontrib>SHIMOMURA, Hiroyuki</creatorcontrib><creatorcontrib>ISHII, Yasushi</creatorcontrib><creatorcontrib>KONDO, Jun-ichi</creatorcontrib><creatorcontrib>FUJIO, Kozo</creatorcontrib><creatorcontrib>IKEDA, Fusao</creatorcontrib><creatorcontrib>MIYAKE, Masanobu</creatorcontrib><creatorcontrib>KUSACHI, Shozo</creatorcontrib><creatorcontrib>TSUJI, Takao</creatorcontrib><title>Prevalence of Hepatitis B and C Virus Markers in Outpatients of Mongolian General Hospitals</title><title>Kansenshogaku Zasshi</title><addtitle>J. J. A. Inf. D</addtitle><description><![CDATA[In East Asian countries, the prevalence of viral hepatitis has been reported to be high, but precise data for each country remained to be investigated. Here we report the prevalence of viral markers of hepatitis B and hepatitis C in outpatient volunteers visiting two general hospitals in Ulaanbaatar, Mongolia. One hundred fifty sera were tested for HBs antigen (HBsAg), anti-HBs, and anti-HCV by Counting Immunoassay. The backgrounds of groups of patients positive for HBsAg and negative for anti-HCV (group 1; n=18), negative for HBsAg and positive for anti-HCV (group 2: n=47), positive for both HBsAg and anti-HCV (group 3; n=25), and negative for both HBsAg and anti-HCV (group 4; n=60) were compared. The prevalence of HBsAg, anti-HBs, and anti-HCV in this study group was 28.7%, 39.3% and 48.0%, respectively. Sugjects of group 1 (mean±SD; 31.3±12.4 years old) were younger than those of group 4 (39.2±14.3; p <0.05), while patients of group 2 (48.7±15.5) were older than those of group 4 (p < 0.01). More group 2 subjects had histories of jaundice (23/47) than those of group 4 (15/60; p <0.05). Transaminase levels were higher in group 1 (median range) IU/ 1 of AST, ALT; 29 (13-95), 32 (9-144) and group 3 (25 (15-187), 22 (8-185)) than in group 4 (18 (9-13), 15 (6-133); p <0.05, p <0.005 vs. group 1, and p <0.005, p <0.001 vs. group 3, respec ively). In HBsAg-negative subjects, those with higher titers of anti-HCV (cut-off index > 15) were older, and had more histories of jaundice and higher levels of AST and ALT than anti-HCV negative subjects (50.3±14.8 vs. 39.1±14.3, p<0.01; 15/28 vs. 15/60, p<0.01; 22.5 (12-127) vs. 18 (9-93), p<0.05; 20.5 (7-362) vs. 15 (6-133), p <0.05; respectively). In conclusion, this preliminary surveillance for hepatitis B and C viral markers showed that both hepatitis viruses are prevalent and may cause liver diseases in Mongolia. A nation-wide survery for these viruses should be urged and preventive measures should be taken to suppress the spread and development of liver diseases in this country.]]></description><subject>Adult</subject><subject>Biomarkers - blood</subject><subject>epidemiology</subject><subject>Female</subject><subject>hepatitic C virus</subject><subject>Hepatitis B - epidemiology</subject><subject>Hepatitis B Antibodies - blood</subject><subject>Hepatitis B Surface Antigens - blood</subject><subject>hepatitis B virus</subject><subject>Hepatitis C - epidemiology</subject><subject>Hepatitis C Antibodies - blood</subject><subject>Hospitals, General</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>mongolia</subject><subject>Mongolia - epidemiology</subject><subject>Outpatients</subject><subject>Prevalence</subject><issn>0387-5911</issn><issn>1884-569X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEFPGzEQha2qiEbAT6jkS3vb1F6v1-tDD20EpBIIkFqE1IM1651N3Gy8wbOLRH89oYlyo5d5h_e9N9Jj7JMUUymlFl9WEAkjLfsFrMa_QLQM0hoxNflUv2MTWVVFpkv78J5NhKpMpq2UH9gZUaiFELYQuc6P2bHVQhljJuz3bcIn6DB65H3L57iBIQyB-HcOseEzfh_SSPwa0goT8RD5zTi8MhgHek1c93HRdwEiv8SICTo-72kTBujolB21W8GzvZ6wXxfnP2fz7Orm8sfs21XmVWV1Zmrb2raRZVWCrrH1AMo2pW6bRolC-ipXUpsGqkqjtkZ6X9tC1gUWRZEbL9UJ-7zr3aT-cUQa3DqQx66DiP1IzlijlDDlFvy6A33qiRK2bpPCGtKzk8L929e9sa8zudPb_Mf9o7FeY3NI79fc-nc7_w8NsMCDD2kIvsP_lcvd0QfWLyE5jOoFqSmcpQ</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>FUJIOKA, Shin-ichi</creator><creator>SHIMOMURA, Hiroyuki</creator><creator>ISHII, Yasushi</creator><creator>KONDO, Jun-ichi</creator><creator>FUJIO, Kozo</creator><creator>IKEDA, Fusao</creator><creator>MIYAKE, Masanobu</creator><creator>KUSACHI, Shozo</creator><creator>TSUJI, Takao</creator><general>The Japanese Association for Infectious Diseases</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1998</creationdate><title>Prevalence of Hepatitis B and C Virus Markers in Outpatients of Mongolian General Hospitals</title><author>FUJIOKA, Shin-ichi ; SHIMOMURA, Hiroyuki ; ISHII, Yasushi ; KONDO, Jun-ichi ; FUJIO, Kozo ; IKEDA, Fusao ; MIYAKE, Masanobu ; KUSACHI, Shozo ; TSUJI, Takao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3895-7b9f9fd1686a5befcaa39d65fdd3041c823157da885e5971ccb941b4e44427c13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adult</topic><topic>Biomarkers - blood</topic><topic>epidemiology</topic><topic>Female</topic><topic>hepatitic C virus</topic><topic>Hepatitis B - epidemiology</topic><topic>Hepatitis B Antibodies - blood</topic><topic>Hepatitis B Surface Antigens - blood</topic><topic>hepatitis B virus</topic><topic>Hepatitis C - epidemiology</topic><topic>Hepatitis C Antibodies - blood</topic><topic>Hospitals, General</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>mongolia</topic><topic>Mongolia - epidemiology</topic><topic>Outpatients</topic><topic>Prevalence</topic><toplevel>online_resources</toplevel><creatorcontrib>FUJIOKA, Shin-ichi</creatorcontrib><creatorcontrib>SHIMOMURA, Hiroyuki</creatorcontrib><creatorcontrib>ISHII, Yasushi</creatorcontrib><creatorcontrib>KONDO, Jun-ichi</creatorcontrib><creatorcontrib>FUJIO, Kozo</creatorcontrib><creatorcontrib>IKEDA, Fusao</creatorcontrib><creatorcontrib>MIYAKE, Masanobu</creatorcontrib><creatorcontrib>KUSACHI, Shozo</creatorcontrib><creatorcontrib>TSUJI, Takao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Kansenshogaku Zasshi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FUJIOKA, Shin-ichi</au><au>SHIMOMURA, Hiroyuki</au><au>ISHII, Yasushi</au><au>KONDO, Jun-ichi</au><au>FUJIO, Kozo</au><au>IKEDA, Fusao</au><au>MIYAKE, Masanobu</au><au>KUSACHI, Shozo</au><au>TSUJI, Takao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of Hepatitis B and C Virus Markers in Outpatients of Mongolian General Hospitals</atitle><jtitle>Kansenshogaku Zasshi</jtitle><addtitle>J. J. A. Inf. D</addtitle><date>1998</date><risdate>1998</risdate><volume>72</volume><issue>1</issue><spage>5</spage><epage>11</epage><pages>5-11</pages><issn>0387-5911</issn><eissn>1884-569X</eissn><abstract><![CDATA[In East Asian countries, the prevalence of viral hepatitis has been reported to be high, but precise data for each country remained to be investigated. Here we report the prevalence of viral markers of hepatitis B and hepatitis C in outpatient volunteers visiting two general hospitals in Ulaanbaatar, Mongolia. One hundred fifty sera were tested for HBs antigen (HBsAg), anti-HBs, and anti-HCV by Counting Immunoassay. The backgrounds of groups of patients positive for HBsAg and negative for anti-HCV (group 1; n=18), negative for HBsAg and positive for anti-HCV (group 2: n=47), positive for both HBsAg and anti-HCV (group 3; n=25), and negative for both HBsAg and anti-HCV (group 4; n=60) were compared. The prevalence of HBsAg, anti-HBs, and anti-HCV in this study group was 28.7%, 39.3% and 48.0%, respectively. Sugjects of group 1 (mean±SD; 31.3±12.4 years old) were younger than those of group 4 (39.2±14.3; p <0.05), while patients of group 2 (48.7±15.5) were older than those of group 4 (p < 0.01). More group 2 subjects had histories of jaundice (23/47) than those of group 4 (15/60; p <0.05). Transaminase levels were higher in group 1 (median range) IU/ 1 of AST, ALT; 29 (13-95), 32 (9-144) and group 3 (25 (15-187), 22 (8-185)) than in group 4 (18 (9-13), 15 (6-133); p <0.05, p <0.005 vs. group 1, and p <0.005, p <0.001 vs. group 3, respec ively). In HBsAg-negative subjects, those with higher titers of anti-HCV (cut-off index > 15) were older, and had more histories of jaundice and higher levels of AST and ALT than anti-HCV negative subjects (50.3±14.8 vs. 39.1±14.3, p<0.01; 15/28 vs. 15/60, p<0.01; 22.5 (12-127) vs. 18 (9-93), p<0.05; 20.5 (7-362) vs. 15 (6-133), p <0.05; respectively). In conclusion, this preliminary surveillance for hepatitis B and C viral markers showed that both hepatitis viruses are prevalent and may cause liver diseases in Mongolia. A nation-wide survery for these viruses should be urged and preventive measures should be taken to suppress the spread and development of liver diseases in this country.]]></abstract><cop>Japan</cop><pub>The Japanese Association for Infectious Diseases</pub><pmid>9503777</pmid><doi>10.11150/kansenshogakuzasshi1970.72.5</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0387-5911 |
| ispartof | Kansenshogaku Zasshi, 1998/01/20, Vol.72(1), pp.5-11 |
| issn | 0387-5911 1884-569X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_79733076 |
| source | J-STAGE Free; MEDLINE; Alma/SFX Local Collection |
| subjects | Adult Biomarkers - blood epidemiology Female hepatitic C virus Hepatitis B - epidemiology Hepatitis B Antibodies - blood Hepatitis B Surface Antigens - blood hepatitis B virus Hepatitis C - epidemiology Hepatitis C Antibodies - blood Hospitals, General Humans Male Middle Aged mongolia Mongolia - epidemiology Outpatients Prevalence |
| title | Prevalence of Hepatitis B and C Virus Markers in Outpatients of Mongolian General Hospitals |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T02%3A42%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20Hepatitis%20B%20and%20C%20Virus%20Markers%20in%20Outpatients%20of%20Mongolian%20General%20Hospitals&rft.jtitle=Kansenshogaku%20Zasshi&rft.au=FUJIOKA,%20Shin-ichi&rft.date=1998&rft.volume=72&rft.issue=1&rft.spage=5&rft.epage=11&rft.pages=5-11&rft.issn=0387-5911&rft.eissn=1884-569X&rft_id=info:doi/10.11150/kansenshogakuzasshi1970.72.5&rft_dat=%3Cproquest_cross%3E79733076%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79733076&rft_id=info:pmid/9503777&rfr_iscdi=true |